Delta Opportunity Funds

Delta Partners is a Boston-based investment management firm that manages the Delta Opportunity Funds. The firm employs a fundamental, research-intensive approach to investing, primarily focusing on small-cap and micro-cap companies in the healthcare, biotechnology, and technology sectors. Delta Partners is recognized for its deep expertise in evaluating clinical-stage biopharmaceutical companies and often takes significant, long-term ownership stakes. The firm's investment strategy is centered on identifying undervalued assets with transformative potential in the life sciences space. Through the Delta Opportunity Funds, the firm provides capital to support the development of innovative therapies and medical technologies. The firm is led by Charles Jobson and has been an active participant in the biotech investment landscape for over two decades.